Leiomodin-1 antibodies were detected in the serum of 6/52 (12%) persons with OAE compared to 14/61 (23%) controls without epilepsy (p = 0.113) by a cell-based assay (Table 4 and Table 5, Figure 1). Here, LMOD1 is linked to epilepsy.